Ypsomed Ltd

Support type: Corporate Pump and Device Supporters
Level: Gold

The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist with over 30 years’ experience. As a leader in innovation and technology, Ypsomed is the preferred partner for pharmaceutical and biotech companies for the supply of injections pens, auto injectors and infusion systems to administer liquid drugs. Ypsomed promotes and sells its product portfolio under the umbrella brand, mylife Diabetescare, offering a range of products and services for people with diabetes. It provides them with everything they need for simple and reliable self-treatment, giving their lives greater freedom and flexibility.

Ypsomed Ltd has its headquarters in Burgdorf, Switzerland, and operates a global network of manufacturing sites, subsidiaries and distributors. The Ypsomed Group employs around 1600 employees.